Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers

Chimeric antigen receptor (CAR) gene-modified T cells (CAR T cells) can eradicate B cell malignancies via recognition of surface-expressed B lineage antigens. Antigen escape remains a major mechanism of relapse and is a key barrier for expanding the use of CAR T cells towards solid cancers with thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Kailayangiri, Sareetha, Altvater, Bianca, Wiebel, Malena, Jamitzky, Silke, Rossig, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281243/
https://www.ncbi.nlm.nih.gov/pubmed/32357417
http://dx.doi.org/10.3390/cancers12051075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281243/
https://www.ncbi.nlm.nih.gov/pubmed/32357417
http://dx.doi.org/10.3390/cancers12051075

Ejemplares similares